| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.97B | $2.94B | $2.78B |
| YoY Revenue Growth % | +1.0% | +5.9% | — |
| Gross Profit | $1.01B | $994.5M | — |
| Gross Margin % | 34.0% | 33.8% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $386.4M | $382.5M | $369.1M |
| Operating Margin % | 13.0% | 13.0% | 13.3% |
| Net Income (GAAP) | $265.4M | $256.6M | $243.7M |
| EBITDA (Normalized) | $442.9M | $453.4M | $469.1M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $371.4M | $340.0M | $340.2M |
| Capital Expenditures (CapEx) | $70.6M | $88.6M | $125.0M |
| Free Cash Flow (FCF) | $300.8M | $251.4M | $215.2M |
| FCF Margin % | 10.1% | 8.5% | 7.7% |
| Return on Invested Capital (ROIC %) | 24.7% | 24.8% | 14.5% |
| Cash & Short-Term Equivalents | $321.9M | $327.6M | — |
| Total Debt (Short + Long Term) | $850.0M | $842.4M | $780.2M |
| Total Stockholders' Equity | $709.9M | $705.3M | $1.60B |